DM population identification: Room for improvement

Adler, David
December 2005
Employee Benefit News;Dec2005, Vol. 19 Issue 15, p37
The article discusses the importance of population identification processes in disease management (DM). DM programs can only work to its full potential if they identify and include patients with chronic illnesses the programs are designed to treat. Well-integrated clinical information systems will make it increasingly easy to find employees who could benefit from DM programs.


Related Articles

  • Principles for Assessing Disease Management Outcomes. Fitzner, Karen; Sidorov, Jaan; Fetterolf, Don; Wennberg, David; Eisenberg, Edward; Cousins, Michael; Hoffman, Joel; Haughton, John; Charlton, Warwick; Krause, David; Woolf, Allen; Mcdonough, Kenneth; Todd, Warren; Fox, Kathe; Plocher, David; Juster, Iver; Stiefel, Matt; Villagra, Victor; Duncan, Ian // Disease Management;Sep2004, Vol. 7 Issue 3, p191 

    Disease management (DM) is rapidly becoming an important force in the late 20th and early21st century as a strategy for managing the chronic illness of large populations. Given the increasingvisibility of DM programs, the clinical, economic and financial impact of this supportare vital to DM...

  • Disease Management: How Plan Sponsors Can Evaluate the Promises and Realities. Garrett, Michael B. // Benefits & Compensation Digest;Feb2006, Vol. 43 Issue 2, p18 

    The article discusses the factors to consider in implementing a disease management program. Disease management programs more typically involve proactive identification with perseverance in contacting employees in order to get them enrolled and engaged in the disease management programs. In...

  • How to start a diabetes management service. Shah, Monica // Drug Topics;9/12/2005, Vol. 149 Issue 17, p36 

    This article provides tips on how to start a diabetes screening and management service program. Before implementing any patient care service, the needs of the patients and other healthcare providers within the community should be assessed. The strengths and weaknesses of the pharmacists should...

  • Accordant health services offers more evidence to show success of disease management programs.  // Insurance Advocate;01/05/2004, Vol. 115 Issue 1, p5 

    Presents the results of the study conducted by Accordant Health Services showing the ability of disease management programs to successfully control costs and improve clinical outcomes in the U.S. Reduction of short and long-term total medical cost trend; Comparison between the Accordant-managed...

  • Tech Talk. Dulcey, John // MGMA Connexion;Nov/Dec2004, Vol. 4 Issue 10, p25 

    The article discusses the use of technology tools in disease management. As the population ages, chronic conditions such as diabetes and hypertension grow increasingly common, and the cost of managing them is rising rapidly. Physician practices need tools to propel disease management to the next...

  • The cost-effectiveness of different management strategies for Type I diabetes: a Swiss perspective. Palmer, A. J.; Weiss, C.; Sendi, P. P.; Neeser, K.; Brandt, A.; Singh, G.; Wenzel, H.; Spinas, G. A. // Diabetologia;Jan2000, Vol. 43 Issue 1, p13 

    Aims/hypothesis. A computer model was developed to determine the health outcomes and economic consequences of different combinations of diabetes interventions in newly diagnosed patients with Type I (insulin-dependent) diabetes in Switzerland.¶Methods. We modelled seven complications of...

  • The socioeconomic burden of rheumatic fever.  // WHO Technical Report Series;2004, Issue 923, p111 

    Discusses key issues concerning the socioeconomic burden posed by rheumatic fever (RF). Cost-effectiveness and control programs; Burden of managing RF and its most important sequel, rheumatic heart disease; Implications on disease management.

  • Path to profitable disease management programs.  // Employee Benefit News;Dec2005, Vol. 19 Issue 15, p42 

    The article talks about profitable disease management (DM) programs. The DM industry grew from $85 million in 1997 to more than $600 million in 2002. According to a review of studies analyzing the economic impact and return on investment (ROI) for disease management programs, inconclusive...

  • Disease Management Outcomes: Are We Asking the Right Questions Yet? Norman, Gordon K. // Population Health Management;Aug2008, Vol. 11 Issue 4, p183 

    The author reflects on the efficacy of disease management (DM) to improve processes of care, adherence to evidence-based guidelines, and clinical outcomes in the U.S. He also examines whether DM programs consistently produce return on investment (ROI), meaning short-term net savings for the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics